Pfizer sues over counterfeit Lipitor

Pfizer sues over counterfeit Lipitor
Pfizer Inc. said Tuesday it was suing two companies connected to counterfeit versions of its cholesterol fighter, Lipitor, the world’s top-selling prescription medicine.

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

June 5, 2003

05 Jun 2003

The ImClone Story: A Hyped Drug, a Tainted Icon

The ImClone Story: A Hyped Drug, a Tainted Icon
It was, in retrospect, a festival of hype emblematic of the boom years, when technology stocks seemed to have nowhere to go but up.

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

June 4, 2003

04 Jun 2003

Five Hurdles for Biotech

Five Hurdles for Biotech
The science is hot and the stocks are up. Here’s what’s needed to deliver on the promise.

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

June 3, 2003

03 Jun 2003

San DNAgo

San DNAgo
Thanks to a fruitful partnership of academia and private enterprise, a vibrant biotech industry keeps on replicating itself.

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

June 3, 2003

03 Jun 2003

Puncturing The ImClone Hype

Puncturing The ImClone Hype
Could ImClone Systems’ Erbitux be a powerful cancer fighter after all? Maybe.

A new study presented June 1 at a meeting of oncologists seems to boost that contention. But there are still reasons to doubt that Erbitux will be approved soon or that it will eventually be a blockbuster.